Meeting
2015 Breast Cancer Symposium
Predictors of chemotherapy-induced peripheral neuropathy among breast cancer patients treated with taxanes.
Authors
Nellowe Candelario
Einstein Medical Center, Philadelphia, PA
Nellowe Candelario , Supakanya Wongrakpanich , Mark S. Morginstin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Systemic Therapy, Survivorship, and Health Policy
Track
Systemic Therapy,Local/Regional Therapy,Survivorship and Health Policy
Sub Track
Quality of Life
Citation
J Clin Oncol 33, 2015 (suppl 28S; abstr 90)
DOI
10.1200/jco.2015.33.28_suppl.90
Abstract #
90
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481).
First Author: Meghna S. Trivedi
Poster
2021 ASCO Annual Meeting
Survival time in urban center breast cancer patients with CNS metastasis with or without visceral metastasis.
First Author: Miriam Pearl Klahr
Poster
2013 ASCO Annual Meeting
Ki-67 level in hormone reptor positive breast cancer patients: A retrospective review of 9,061 Korean women.
First Author: Jisun Kim
Poster
2012 ASCO Annual Meeting
Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study.
First Author: Linda Sharp